2 news · updated Jun 17, 2026

FDA Moderna flu shot

2026-06-16

Moderna Flu Shot Data May Support Use in Older Adults, US FDA Staff Says

US FDA staff indicated Moderna's mFlusiva flu shot data supports effectiveness in adults 65+. An advisory committee votes June 18 on approval for ages 50+, potentially making it the first mRNA seasona

reuters · 2026-06-16 06:12 UTC

2026-02-18

‘Regulatory whiplash’ as FDA decides to review Moderna flu shot

The FDA reversed course to review Moderna’s mRNA flu vaccine under an amended pathway, splitting approval requests by age group. Full approval is sought for ages 50–64, while adults 65+ face accelerat

cen · 2026-02-18 00:00 UTC

FDA Moderna flu shot

Moderna Flu Shot Data May Support Use in Older Adults, US FDA Staff Says

‘Regulatory whiplash’ as FDA decides to review Moderna flu shot

Media coverage (2)

Related topics